10 Papers
10 Citations
Lu Li is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 5, co-authored 6 publications.
Chat about Author
Papers
Development and validation of a clinically applicable score to classify cachexia stages in advanced cancer patients
TL;DR: This study aimed to develop a clinically applicable cachexia staging score (CSS) and validate its discrimination of clinical outcomes for different cachexia stages.
61
A new index based on serum creatinine and cystatin C is useful for assessing sarcopenia in patients with advanced cancer.
Xiaofen Fu,Zhen Tian,Su Wen,Huihui Sun,Sudip Thapa,Huihua Xiong,Huiquan Liu,Lu Li,Shiying Yu +8 more
TL;DR: The SI might be a useful objective tool for assessing sarcopenia in patients with advanced cancer, and a decrease in the SI was associated with a higher likelihood of sarc Openia.
54
Cancer-related fatigue and biochemical parameters among cancer patients with different stages of sarcopenia
TL;DR: It is suggested that sarcopenia may be a crucial target to improve the management of CRF and Circulating albumin and cholinesterase have the potential to predicting sarc Openia as biomarkers.
35
Pharmacological Inhibition of HMGB1 Prevents Muscle Wasting
TL;DR: In this article, the effect of CT26 exosomes on C2C12 myotubes was observed and the HMGB1 inhibitor glycyrrhizin was used to reverse the effects of HMGB 1 on the myo-tube.
17
Annexin A1 promotes the progression of bladder cancer via regulating EGFR signaling pathway
Piao Li,Lingling Li,Zhou Li,Shen-Nan Wang,Ruichao Li,Weiheng Zhao,Ya-ling Feng,Shanshan Huang,Lu Li,Hong Qiu,Shu Xia +10 more
TL;DR: In this paper , the clinical relevance of ANXA1 in BLCA was investigated by bioinformatics analysis based on TCGA and GEO datasets, and immunohistochemical (IHC) analysis was performed to detect the expression of ANAXA1 and clinical parameters were analyzed.